3 ms·
Sure that’s how it works. Average R&D spend is ~20%, so 20% of the price paid goes back into R&D right now. And yes, money goes back to investors who often re
by refurb 5y ago
Sure that’s how it works. Average R&D spend is ~20%, so 20% of the price paid goes back into R&D right now.
And yes, money goes back to investors who often reinvest it into biotech.
- bpodgursky 5y agoIt amuses me to imagine, how grandparent imagines investors cash out of biotech: buying a large pool of gold and swimming in it? If you make a billion dollars on biotech... it has to go somewhere (banks are for chumps!), so it's going back into either the public market, or venture capital. And if you made a billion on biotech once....
- refurb 5y agoSimilar to tech, the founders who walk away with billions start their own funds as well.